Exploratory analysis In the semaglutide group, %WL did not significantly differ with age, ethnicity, diabetes status, sex, type of surgery, time from surgery (months), baseline meal-stimulated GLP-1 change, postoperative %WL (from date of surgery (DOS) to randomization), maximum %WL achieved after surgery or MBS response (weight regain versus suboptimal post-surgery weight loss)
How to choose Want structure and coaching
Clinical evidence The 2013 exenatide proof-of-concept clinical trial involving 45 moderate PD patients displayed possible efficacy concerning part 3 of the Movement Disorders Society Unified Parkinsons Disease Rating Scale (MDS-UPDRS) [17]
Eur Heart J - Cardiovasc Pharmacother (2023), pvad080
CJC-1295 and Ipamorelin are growth-hormone secretagogues studied for lean mass and recovery, while BPC-157 and TB-500 are tissue-repair peptides linked to faster recovery from training strain
Depends on per-session amount and sessions per month